Skip to content

MI MAPA 2023 Fall Conference | Intensifying Diabetes Therapies to Achieve Personalized Treatment Goals

Mihail Zilbermint, MD, MBA, FACE

1.Name
2.Email
3.What is your professional designation?(Required.)
4.What is your specialty track?(Required.)
5.What setting do you practice in?(Required.)
6.How many patients do you see per month?(Required.)
7.Commercial Bias Definition: The Accreditation Council for Continuing Medical Education (ACCME) defines "commercial bias" as a personal judgment in favor of a specific proprietary business interest of a commercial interest. Based upon the ACCME's definition above, do you feel there was any commercial bias in this program?
8.The faculty/speaker demonstrated experiential knowledge of the topic.
9.As a result of my participation in this activity, I am better able to recognize the connection between managing T2D and how other serious complications, such as cardiovascular and chronic kidney disease, can also be avoided.
10.As a result of my participation in this activity, I am better able to identify methods to intensify therapies to reach timely, sustained glycemic control targets (GLP-1 RA info).
11.As a result of my participation in this activity, I am better able to apply shared decision-making strategies with sustained glycemic control targets and personalized treatment/management as critical goals in persons with diabetes to prevent long-term health implications. 
12.Overall, I am satisfied with the program. 
13.The content provided a fair and balanced coverage of the topic.
14.The content of the activity was relevant to my practice.
15.After participating in this activity, my knowledge of the subject matter has increased significantly.
16.The activity increased my competence. 
17.Do you plan to make changes in your practice as a result of attending this activity? If you do not, please share why.
18.Please identify any changes in your practice that could occur as a result of your participation in the session. 
19.Please identify any barriers or challenges that could prevent you from implementing these changes in your practice.
20.What additional endocrinology issues do you face in your practice?
21.What additional endocrinology content would be of interest to you?